Romina Goldszmid | Academic Influence

Romina Goldszmid's AcademicInfluence.com Rankings

Romina Goldszmid

Biology

#12678

World Rank

#16169

Historical Rank

Cell Biology

#898

World Rank

#922

Historical Rank

biology Degrees

Download Badge

Biology

Romina Goldszmid's Degrees

Bachelors Biology University of Buenos Aires

Similar Degrees You Can Earn

Best Online Bachelor's in Biology 2025

Why Is Romina Goldszmid Influential?

(Suggest an Edit or Addition)

According to Wikipedia, Silvana Romina Goldszmid is an Argentine-American biologist researching tumor immunology. She is an NIH Stadtman Investigator at the National Cancer Institute. Education Romina Goldszmid completed a M.S. in biochemistry and a Ph.D. in tumor immunology working on dendritic cell-based vaccines for melanoma immunotherapy from the University of Buenos Aires, part of which was performed as a visiting scholar in the laboratory of Ralph M. Steinman at the Rockefeller University. In 2004, she came to the National Institutes of Health to conduct postdoctoral research in infectious disease immunology with Alan Sher in the Laboratory of Parasitic Diseases at the National Institute of Allergy and Infectious Diseases .

(See a Problem?)

Romina Goldszmid's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

Commensal Bacteria Control Cancer Response to Therapy by Modulating the Tumor Microenvironment (2013) (1525)
Conventional T-bet+Foxp3− Th1 cells are the major source of host-protective regulatory IL-10 during intracellular protozoan infection (2007) (635)
CD8α(+) dendritic cells are the critical source of interleukin-12 that controls acute infection by Toxoplasma gondii tachyzoites. (2011) (353)
Infected site-restricted Foxp3+ natural regulatory T cells are specific for microbial antigens (2006) (347)
Cutting Edge: TLR9 and TLR2 Signaling Together Account for MyD88-Dependent Control of Parasitemia in Trypanosoma cruzi Infection1 (2006) (312)
IL-12 triggers a programmatic change in dysfunctional myeloid-derived cells within mouse tumors. (2011) (299)
NK cell-derived interferon-γ orchestrates cellular dynamics and the differentiation of monocytes into dendritic cells at the site of infection. (2012) (248)
Dendritic Cells Charged with Apoptotic Tumor Cells Induce Long-Lived Protective CD4+ and CD8+ T Cell Immunity against B16 Melanoma 1 (2003) (199)
The role of the microbiota in inflammation, carcinogenesis, and cancer therapy (2015) (189)
The price of immunity (2012) (160)
Host ER–parasitophorous vacuole interaction provides a route of entry for antigen cross-presentation in Toxoplasma gondii–infected dendritic cells (2009) (149)
Leishmania Antigens Are Presented to CD8+ T Cells by a Transporter Associated with Antigen Processing-Independent Pathway In Vitro and In Vivo (2006) (130)
Host immune response to infection and cancer: unexpected commonalities. (2014) (122)
Microbiota triggers STING-type I IFN-dependent monocyte reprogramming of the tumor microenvironment (2021) (113)
Gut microbiome and anticancer immune response: really hot Sh*t! (2014) (98)
The pivotal role of IKKα in the development of spontaneous lung squamous cell carcinomas. (2013) (90)
TAP-1 indirectly regulates CD4+ T cell priming in Toxoplasma gondii infection by controlling NK cell IFN-γ production (2007) (69)
Systemic Inflammation in Cachexia – Is Tumor Cytokine Expression Profile the Culprit? (2015) (68)
Microbiota—myeloid cell crosstalk beyond the gut (2016) (59)
Inflammatory changes after cryosurgery-induced necrosis in human melanoma xenografted in nude mice. (2001) (53)
Dendritic Cell Activation Prevents MHC Class II Ubiquitination and Promotes MHC Class II Survival Regardless of the Activation Stimulus* (2010) (53)
Multimodel preclinical platform predicts clinical response of melanoma to immunotherapy (2020) (50)
Can we harness the microbiota to enhance the efficacy of cancer immunotherapy? (2020) (41)
Microbiota Modulation of Myeloid Cells in Cancer Therapy (2015) (38)
Harnessing the intestinal microbiome for optimal therapeutic immunomodulation. (2014) (36)
Processing and presentation of antigens derived from intracellular protozoan parasites. (2010) (29)
Abstract 1083: The pivotal role of IKKalpha in the development of spontaneous lung squamous cell carcinomas. (2013) (23)
Why should we need the gut microbiota to respond to cancer therapies? (2014) (17)
IFNAR1 Degradation: A New Mechanism for Tumor Immune Evasion? (2017) (16)
Interleukin-1 and Interferon-γ Orchestrate β-Glucan-Activated Human Dendritic Cell Programming via IκB-ζ Modulation (2014) (13)
Two Bugs a NOD Away from Improving Cancer Therapy Efficacy. (2016) (10)
Multimodel preclinical platform predicts clinical response of melanoma to immunotherapy (2019) (7)
Inflammation in the Disease: Mechanism and Therapies 2014 (2015) (7)
Recognition of observer effect is required for rigor and reproducibility of preclinical animal studies. (2022) (6)
Short Course in the Microbiome (2015) (5)
Characterization of the tumor immune infiltrate by multiparametric flow cytometry and unbiased high-dimensional data analysis. (2020) (4)
Beating Cancer with a Gut Feeling. (2015) (4)
Vitro and In Vivo Antigen Processing-Independent Pathway In T Cells by a Transporter Associated with + Antigens Are Presented to CD 8 Leishmania (2006) (2)
Can gut microbes predict efficacy and toxicity of combined immune checkpoint blockade? (2021) (2)
CD8α[superscript +] Dendritic Cells Are the Critical Source of Interleukin-12 that Controls Acute Infection by Toxoplasma gondii Tachyzoites (2011) (2)
regulatory T cells are specifi c for microbial antigens (2006) (2)
Microbiota Modulation of Myeloid Cells in Cancer (2015) (2)
Sentinel and Regulatory Functions of Dendritic Cells in the Immune Response to Toxoplasma gondii (2008) (2)
Double stranded RNA tricks melanoma cells into committing suicide (2009) (1)
Abstract 1782:Acidovorax temperansmodulates the host immune microenvironment to promote lung cancer development (2021) (1)
Infection Trypanosoma cruzi Control of Parasitemia in Together Account for MyD 88-Dependent Cutting Edge : TLR 9 and TLR 2 Signaling (2006) (1)
Trypanosoma cruzi Control of Parasitemia in Together Account for MyD88-Dependent Cutting Edge: TLR9 and TLR2 Signaling (2006) (0)
Gut commensal bacteria promote anti-tumor innate immune responses in distant tumors after immunotherapy and chemotherapy (162.5) (2012) (0)
IL-1 and IFN-gamma differentially program human dendritic cells exposed to beta-glucan via IkappaB-zeta regulation (P6279) (2013) (0)
TAP-1 indirectly regulates CD4 (cid:2) T cell priming in Toxoplasma gondii infection by controlling NK cell IFN- (cid:2) production (2007) (0)
Abstract B80: Gut commensal bacteria promote antitumor innate immune responses in distant tumors after immunotherapy and chemotherapy. (2013) (0)
Short Course in the Microbiome The Harvard community has made this article openly available. Please share how this access benefits you. Your story matters (2016) (0)
Author Correction: Multimodel preclinical platform predicts clinical response of melanoma to immunotherapy (2021) (0)
Microbes-myeloid-tumor: a colonic triad against T cells. (2022) (0)
Neutrophil dynamics in the tumor microenvironment determines therapy efficacy and is regulated by microbiota (2022) (0)
Short Course in the Microbiome Meeting Dispatch (2016) (0)
Course in the Microbiome (2016) (0)
Infection 3 Protozoal and helminth infection (SY1-5) Chairpersons: Kenji Nakanishi, Maria Yazdanbakhsh (2010) (0)
Abstract 5188: Interrogating the role of the immune microenvironment in the response of brain metastases to immunotherapy using new preclinical melanoma models (2023) (0)
Tumor-intrinsic factors dictate beneficial effect of microbiota-based therapies (2022) (0)
CD 8 [ superscript + ] Dendritic Cells Are the Critical Source of Interleukin-12 that Controls Acute Infection by Toxoplasma gondii (2011) (0)
Células dendríticas en la inmunoterapia del cáncer : desarrollo de una vacuna anti-melanoma en un modelo experimental (2003) (0)
B16 Melanoma T Cell Immunity against + and CD8 + CD4Tumor Cells Induce Long-Lived Protective Dendritic Cells Charged with Apoptotic (2003) (0)

This paper list is powered by the following services:

Other Resources About Romina Goldszmid

en.wikipedia.org

What Schools Are Affiliated With Romina Goldszmid?

Romina Goldszmid is affiliated with the following schools: